Starton Therapeutics
Tuesday, February 27, 2024
Uris
Oncology
Starton is a clinical-stage biotechnology company transforming standard of care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, longer.
State
New Jersey
Country
United States
Website
https://www.startontx.com/
CEO/Top Company Official
Pedro Lichtinger - Chairman and CEO
Lead Product in Development
STAR-LLD (Multiple Myeloma/Chronic Lymphocytic Leukemia)
Development Phase of Primary Product
Phase I
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
)
)
){kind=logo}